Access To Medicines

Every minute, somewhere in the world a woman or girl has an unsafe abortion. MSF is committed to providing safe abortion care to reduce avoidable suffering and deaths.

Unsafe abortion is one of the main causes of maternal death worldwide, and the only one that is almost entirely preventable.

Every day, our teams around the world witness first-hand the death and suffering caused by unwanted pregnancy and unsafe abortion.

That’s how we know that safe abortion care is essential healthcare.

MSF's Impact

In response to the need for better treatments, vaccines and diagnostic tests MSF set up its Access Campaign in 1999 to improve care for patients.

The aims of MSF Access Campaign are to:

  • Push for price cuts to medicines, vaccines and diagnostic tests by stimulating the production of more affordable generic products     
  • Act as a watchdog to ensure that the corporate interests don’t win out over public health needs     
  • Steer the direction of medical research toward urgently needed new drugs, vaccines and tests that don’t exist yet or are not tailored to the needs of people in developing countries     
  • Scope out, support and monitor new models to fund medical research that respond to medical rather than corporate needs and do not rely on charging sky high prices for the final product to pay for the research     

In 2003, MSF joined forces with six other organisations from around the world to establish the Drugs For Neglected Diseases Initiative (DNDi), with the aim of developing new drugs or new formulations of existing drugs for patients suffering from the most neglected communicable diseases.

DNDi seeks to address unmet needs by taking on projects that others are unable or unwilling to pursue.
 

MSF is well known for its humanitarian medical work, but it has also produced important research based on its field experience with vulnerable communities .

This website archives MSF's scientific articles and makes them available free, with full text and in an easily searchable format. MSF Field Research website.

MSF is also pushing for increased research into neglected diseases – such as tuberculosis, malaria, sleeping sickness and leishmaniasis – through increased funding, investing in research and development (R&D) capability in developing countries and supporting alternative models for R&D

Some treatments are no longer produced. MSF is calling on companies and governments to find solutions to bring unprofitable but medically necessary drugs back into production.

MSF is also supporting developing countries in codifying into law the "safeguards" that are allowed under international trade rules in order to protect access to medicines.

 
On 2 April MSF sent a small team to Mocímboa de Praia, a coastal town in the northern Mozambican province of Cabo Delgado.
Mozambique

MSF will adapt critical healthcare in Mocímboa da Praia as people return home

Press Release 8 Apr 2022
 
MSF, Doctors Without Borders, Ukraine, Medical train referral
War in Ukraine

“You have a medical train? I have patients for you”

Patient and Staff Stories 6 Apr 2022
 
UKRAINE. Pisky. 22 February 2022. A school destroyed during the fighting. MSF has been working in eastern Ukraine for the last eight years, trying to improve access to health care for remote, conflict-affected populations.
War in Ukraine

Mariupol hospital attack

Press Release 10 Mar 2022
 
Advanced HIV patient lying on a cloth on the ground
HIV/AIDS

ViiV will not license new game-changing long-acting HIV prevention drug to generic manufacturers

Press Release 4 Mar 2022
 
MSF, Doctors Without Borders, Ukraine
Ukraine

Our teams are looking into how they can adapt MSF's activities to respond in Ukraine

Press Release 25 Feb 2022
 
MSF, Doctors Without Borders, Niger, Niger airstrike on village and civilians
Armed conflict

MSF team helps treat injured children after the bombing of a village on Nigerian border

Press Release 21 Feb 2022